What is Shanghai Fosun Pharmaceutical (Group) Co E10?
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Dec. 2024 was HK$0.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is HK$0.75 for the trailing ten years ended in Dec. 2024.
During the past 3 years, the average E10 Growth Rate was 1.00% per year.
During the past 5 years, the average E10 Growth Rate was 4.60% per year.
During the past 10 years, the average E10 Growth Rate was 7.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.
During the past 13 years, the highest 3-Year average E10 Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 15.90% per year. The lowest was 1.00% per year. And the median was 11.20% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shanghai Fosun Pharmaceutical (Group) Co E10 Chart
Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's E10
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry
Shanghai Fosun Pharmaceutical (Group) Co E10 Calculation
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.
What is E10? How do we calculate E10?
E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.
We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
per share eps
CPI
Adj_EPS
201503
0.286
99.900
0.329
201506
0.412
99.500
0.476
201509
0.304
100.500
0.348
201512
0.288
100.600
0.329
201603
0.322
102.200
0.362
201606
0.448
101.400
0.508
201609
0.337
102.400
0.378
201612
0.292
102.600
0.327
201703
0.349
103.200
0.389
201706
0.435
103.100
0.485
201709
0.345
104.100
0.381
201712
0.332
104.500
0.365
201803
0.348
105.300
0.380
201806
0.425
104.900
0.465
201809
0.229
106.600
0.247
201812
0.273
106.500
0.295
201903
0.327
107.700
0.349
201906
0.352
107.700
0.376
201909
0.242
109.800
0.253
201912
0.545
111.200
0.563
202003
0.254
112.300
0.260
202006
0.482
110.400
0.502
202009
0.341
111.700
0.351
202012
0.545
111.500
0.562
202103
0.394
112.662
0.402
202106
0.773
111.769
0.795
202109
0.506
112.215
0.518
202112
0.563
113.108
0.572
202203
0.222
114.335
0.223
202206
0.492
114.558
0.493
202209
0.380
115.339
0.379
202212
0.547
115.116
0.546
202303
0.421
115.116
0.420
202306
0.328
114.558
0.329
202309
0.193
115.339
0.192
202312
0.033
114.781
0.033
202403
0.250
115.227
0.249
202406
0.248
114.781
0.248
202409
0.319
115.785
0.317
202412
0.310
114.893
0.310
Add all the adjusted EPS together and divide 10 will get our e10.
Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) E10 Explanation
If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.
For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.
The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Shanghai Fosun Pharmaceutical (Group) Co's Shiller P/E Ratio of today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
During the past 13 years, the highest Shiller P/E Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 68.81. The lowest was 16.20. And the median was 28.43.
Be Aware
Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.
Shanghai Fosun Pharmaceutical (Group) Co E10 Related Terms
Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Fosun Pharmaceutical (Group) Co Business Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02196 has been successfully added to your 